Identification of biomarkers correlated with diagnosis and prognosis of endometrial cancer using bioinformatics analysis

Journal of Cellular Biochemistry
Huishan ZhaoHongchu Bao

Abstract

Endometrial cancer (EC) is one of the most common malignancies in the female genital system, characterized by high mortality and recurrence rates. This study attempted to screen key genes and potential prognostic biomarkers for EC using bioinformatics analysis. Twenty-seven normal endometrial tissues and 135 EC samples were collected from four Gene Expression Omnibus (GEO) databases, then we identified the differentially expressed genes (DEGs) and conducted downstream analyses. Moreover, we screened hub genes by constructing a protein-protein interaction (PPI) network. Finally, we assessed the prognostic values and molecular mechanism of the potential prognostic genes using the Kaplan-Meier curve and Gene Set Enrichment Analysis (GSEA). As a result, 28 upregulated and 94 downregulated genes were determined after gene integration of these four GEO data sets. Gene Ontology analysis indicated that DEGs were mainly involved in transcriptional regulation and cell proliferation. The Kyoto Encyclopedia of Gene and Genome pathway analysis primarily related to transcriptional misregulation and apoptosis. Moreover, the PPI analysis revealed 10 hub genes (JUN, UBE2I, GATA2, WT1, PIAS1, FOXL2, RUNXI, EZR, TCF4, and NR2F2) with a high degre...Continue Reading

References

Dec 11, 1999·Nucleic Acids Research·M Kanehisa, S Goto
Aug 14, 2003·Human Molecular Genetics·Donna G Albertson, Daniel Pinkel
Dec 31, 2005·Nucleic Acids Research·UNKNOWN Gene Ontology Consortium
Jul 20, 2006·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Xuesong Lu, Xuegong Zhang
May 15, 2007·Bioinformatics·Sean Davis, Paul S Meltzer
Dec 22, 2009·Cell Adhesion & Migration·Amparo Cano, Francisco Portillo
Sep 12, 2012·Journal of Molecular Endocrinology·Lacey M Litchfield, Carolyn M Klinge
Mar 30, 2013·Science·Bert VogelsteinKenneth W Kinzler
Sep 21, 2013·Journal of Molecular Endocrinology·Adrien GeorgesReiner A Veitia
Mar 7, 2014·Trends in Molecular Medicine·Marc P ForrestDerek J Blake
Oct 7, 2014·Acta Pharmacologica Sinica·Mafei XuMing-Jer Tsai
Oct 21, 2014·Cell & Bioscience·Jun QinMing-Jer Tsai
Feb 5, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·XueLian LiQi Chen
Sep 12, 2015·Lancet·Philippe MoriceEmile Darai
Dec 8, 2016·Nucleic Acids Research·Damian SzklarczykChristian von Mering
Dec 13, 2016·Current Opinion in Obstetrics & Gynecology·Yeh C LeeAmit M Oza
May 26, 2017·Cellular & Molecular Biology Letters·Hideyuki IshiguroHiromitsu Takeyama
Feb 9, 2018·Reproductive Biology and Endocrinology : RB&E·Michal ElbazEran Gershon
Aug 11, 2018·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Haruko IwaseTakashi Onda
Jan 8, 2019·Cancer Biomarkers : Section a of Disease Markers·Longyang LiuXin Feng
Apr 21, 2019·Obesity Research & Clinical Practice·Yeong Sook YoonSang Woo Oh
Apr 26, 2019·The Journal of International Medical Research·Tianjiao LyuWeiwei Feng
May 1, 2019·Journal of Cellular Biochemistry·Yong SongQi-Qiang He
Jun 22, 2019·BMC Molecular and Cell Biology·Yangyang HanMin Cheng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis